Prospective evaluation of the diagnostic value of sensitive KIT D816V mutation analysis of blood in adults with suspected systemic mastocytosis
- 16 May 2017
- Vol. 72 (11), 1737-1743
- https://doi.org/10.1111/all.13187
Abstract
Sensitive KIT D816V mutation analysis of blood has been proposed to guide bone marrow (BM) investigation in suspected systemic mastocytosis (SM). The aim of this prospective study was for the first time to compare the D816V status of the “screening blood sample” used to guide BM biopsy in suspected SM to the outcome of the subsequent BM investigation. Fifty-eight adult patients with suspected SM were included. The outcome of sensitive KIT D816V analysis of blood was compared to the result of the BM investigation. Screening blood samples from 44 of 58 patients tested D816V-positive. In 43 of these, SM was subsequently diagnosed in the BM investigation. One patient with a D816V-positive screening sample was diagnosed with monoclonal MC activation syndrome. Screening blood samples from 14 patients tested D816V-negative. SM was subsequently diagnosed in five of these, whereas nine patients did not fulfill any diagnostic SM criteria (excluding tryptase criterion). Of the 48 SM patients, 90% tested D816V-positive. Thirteen SM patients presented with Hymenoptera venom-induced anaphylaxis, no skin lesions, and baseline serum tryptase ≤20 ng/mL. Of these, 92% tested D816V-positive in the screening blood sample. This prospective study demonstrates that a D816V-positive result in a screening blood sample identifies SM among patients with hymenoptera venom-induced anaphylaxis in whom the diagnosis would most probably have been missed, with potential severe implications. The observed false-negative screening results also underline that BM investigation is mandatory in all adult patients with clear signs of, or highly suspected SM, regardless of the KIT mutation status.Keywords
This publication has 25 references indexed in Scilit:
- Risk of solid cancer, cardiovascular disease, anaphylaxis, osteoporosis and fractures in patients with systemic mastocytosis: A nationwide population‐based studyAmerican Journal of Hematology, 2016
- Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patientsAmerican Journal of Hematology, 2016
- Morphologically Occult Systemic Mastocytosis in Bone MarrowAmerican Journal of Clinical Pathology, 2015
- Mast Cells, Mastocytosis, and Related DisordersNew England Journal of Medicine, 2015
- High prevalence of fractures and osteoporosis in patients with indolent systemic mastocytosisAllergy, 2012
- Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patientsAllergy, 2008
- Standards and standardization in mastocytosis: Consensus Statements on Diagnostics, Treatment Recommendations and Response CriteriaEuropean Journal of Clinical Investigation, 2007
- Diagnostic Value of Tryptase in Anaphylaxis and MastocytosisImmunology and Allergy Clinics of North America, 2006
- Diagnostic criteria and classification of mastocytosis: a consensus proposalLeukemia Research, 2001
- Fatal anaphylaxis after a yellow jacket sting, despite venom immunotherapy, in two patients with mastocytosisJournal of Allergy and Clinical Immunology, 1997